Alto's Brainy Bonanza: Neuroscience Powerhouse ANRO Unleashes $128.6M IPO Surge

In a move that adds an intriguing layer to the IPO dynamics, Alto has granted underwriters a 30-day option to scoop up an additional 1,206,000 shares of co...

February 02, 2024 | Friday | News
Carcinotech Secures $5.3M Funding to Boost Global Expansion of Carcino3D Technology

Carcinotech has raised $5.3 million of funding as the company looks to build on its traction in the UK and Europe, with US expansion planned later this yea...

January 31, 2024 | Wednesday | News
DelSiTech Secures EUR 10M Funding to Advance Silica-Based Drug Delivery Platform

New investment from DRW Venture Capital LLC and Tolmar International Ltd Funds will be used to advance its proprietary, silica-based, drug delivery...

January 16, 2024 | Tuesday | News
Illumina Ventures Labs Launches in US and UK for Accelerated Health Start-Up Growth

Illumina Ventures Labs is part of Illumina Ventures, the premier genomics and precision health venture firm supporting early-stage companies transforming h...

January 12, 2024 | Friday | News
mPulse Acquires HealthTrio and Decision Point Healthcare Solutions to Bolster Healthcare Digital Engagement Position

The strategic acquisition of HealthTrio, a leading provider of comprehensive health management and member engagement solutions, and Decision Point, an inno...

December 20, 2023 | Wednesday | News
ImpriMed Secures $23M in Series A to Expand AI-Powered Cancer Treatment Technology

ImpriMed, a leading precision medicine startup focused on leveraging artificial intelligence to improve cancer treatment,  announced the close of a $2...

December 20, 2023 | Wednesday | News
Perpetual Medicines Raises $8M in Seed Round for Peptide Drug Discovery Platform

Perpetual Medicines  announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for pe...

December 04, 2023 | Monday | News
Hovione Acquires ExtremoChem for Enhanced Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecules found in extremoph...

November 21, 2023 | Tuesday | News
ABC Medical Introduces Groundbreaking Behavioral Health Treatment Program

ABC Medical, a behavioral healthcare start-up, headquartered in Reading, Massachusetts, wants to offer an alternative – a comprehensive treatment pro...

November 20, 2023 | Monday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...

November 17, 2023 | Friday | News
T-Therapeutics Secures £48M in Series A for Advancing Next-Gen TCR Therapeutics in Cancer Treatment Transformation.

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofin...

November 16, 2023 | Thursday | News
BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market

BioPhy  launched its AI operating system that radically accelerates the identification and development of the most promising drug candidates. By combi...

November 08, 2023 | Wednesday | News
Japanese Startup Buzzreach Becomes First to Join U.S. Decentralized Trials & Research Alliance

Buzzreach is engaged in the development of a clinical trial and clinical research platform business that leverages the power of technology to address the c...

October 20, 2023 | Friday | News
Astrazeneca Foundation Awards 12 Nonprofit Organizations More Than $2M to Advance Health Equity

AstraZeneca Foundation celebrates its 30th anniversary, the organization has awarded 12 nonprofit organizations $2,170,318 in grants across eight US states...

October 11, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close